Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Tong Ren Tang Technologies Co ( (HK:1666) ) has shared an update.
Tong Ren Tang Technologies Co. Ltd. has announced amendments to the terms of reference for its Audit Committee, which were adopted by the Board on August 18, 2025. The changes emphasize the importance of having a majority of Independent Non-Executive Directors in the committee, including at least one member with professional qualifications in accounting or financial management. This move is expected to enhance the company’s compliance with the Hong Kong Stock Exchange’s Listing Rules, potentially strengthening its governance and transparency, which could positively impact stakeholders’ trust.
More about Tong Ren Tang Technologies Co
Tong Ren Tang Technologies Co. Ltd. is a company incorporated in the People’s Republic of China, focusing on the pharmaceutical industry. It is known for its production and distribution of traditional Chinese medicine products.
YTD Price Performance: 6.84%
Average Trading Volume: 1,470,871
Technical Sentiment Signal: Buy
Current Market Cap: HK$6.83B
Find detailed analytics on 1666 stock on TipRanks’ Stock Analysis page.